Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07262138 · ClinicalTrials.gov registry record
Active Surveillance in Older Women With ER+ Breast Cancer
A clinical trial of Early Stage Estrogen Receptor (ER) Positive Breast Cancer, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT07262138 is a study of Early Stage Estrogen Receptor (ER) Positive Breast Cancer that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07262138, a study of Early Stage Estrogen Receptor (ER) Positive Breast Cancer, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
ACTIVE is a prospective, single-arm, phase I/IIa study examining an active surveillance strategy for small, screen-detected, luminal breast cancer. Patients aged 70 or older with clinical stage I ER+/HER2- breast cancer are eligible. The goal of this clinical trial is to learn if an active surveillance strategy (serial imaging rather than therapeutic intervention) is a safe approach to monitor small breast cancers. The main question to answer is the proportion of participants who experience tumor progression by 12 months.
Conditions Studied
Interventions
- OTHER Active Surveillance
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07262138
The ClinicalTrials.gov registry entry for NCT07262138 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Early Stage Estrogen Receptor (ER) Positive Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Active Surveillance is the first listed.
NCT07262138 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07262138 about?
NCT07262138 is a clinical study titled "Active Surveillance in Older Women With ER+ Breast Cancer". ACTIVE is a prospective, single-arm, phase I/IIa study examining an active surveillance strategy for small, screen-detected, luminal breast cancer. Patients aged 70 or older with clinical stage I ER+/HER2- breast cancer are eligible. The goal of this clinical trial is to learn if an active surveilla...
What is the current status of trial NCT07262138?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-11-01. Estimated completion is 2030-12-31.
What conditions does trial NCT07262138 study?
This clinical trial studies the following conditions: Early Stage Estrogen Receptor (ER) Positive Breast Cancer.
What interventions are being tested in trial NCT07262138?
The interventions under investigation include: Active Surveillance (OTHER).
Who is sponsoring clinical trial NCT07262138?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07262138 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.